latest thinking on treating osteoporosis in postmenopausal women

April 2002

Here's the latest thinking on treating osteoporosis in postmenopausal women.

Fosamax and Actonel are widely-used oral bisphosphonates. They increase bone density and prevent fractures by inhibiting bone resorption. But some patients can't take them due to GI side effects.

Zometa (zoledronic acid) is also a bisphosphonate, but it's given IV. It's recently approved for hypercalcemia and bone metastases in cancer patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote